Australian Healthcare Players See Wage Indexation Benefits, Margin Expansion in Fiscal 2025, Jarden Research Says

MT Newswires Live09-23

Australian healthcare players Integral Diagnostics (ASX:IDX) and Capitol Health (ASX:CAJ) should benefit from additional wage indexation in fiscal 2025, while Sonic Healthcare (ASX:SHL) and Healius (ASX:HLS) are expected to remain "hurt" by the lack of indexation, according to a Sept. 18 note from Jarden Research.

Meanwhile, Ramsay Healthcare (ASX:RHC) and Regis Healthcare (ASX:REG) should benefit from lower agency costs, with Ramsay remaining in negotiations on enterprise bargaining agreements in Western Australia and New South Wales, Australia, the investment firm stated.

CSL (ASX:CSL) ResMed (ASX:RMD) has shown margin expansion due to management improving operating margins, with ResMed's initial concern of higher freight costs on margins "more than offset" as expectations it will normalize into fiscal 2025, according to the note.

ResMed, Cochlear (ASX:COH), Regis Healthcare, and Sonic Healthcare appear to Jarden Research to be best positioned for more mergers and acquisitions and capital management, while Healius and Ramsay Healthcare are looking at selling assets to optimize their portfolios, the investment firm said.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment